Genomics Inc (NASDAQ:TXG) stock is trading lower after the company, on Wednesday, released preliminary financial results for ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium ...

Genomics has impressive financials but isn't expected to be profitable until at least 2028. Read more to see why I'm bearish ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10x Genomics’ instruments sales fell significantly ... During its second quarter 2024 earnings release, the gene sequencing company cut its fiscal year 2024 sales guidance to $640 million ...

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, ...

Advances in DNA sequencing and the vast amounts of genomic data being produced by next-generation sequencing (NGS) technology ...

DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA. Sanger sequencing by replicative synthesis in the presence of ...

This is the most recent in a string of rulings against 10x in its efforts to use litigation ... Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its ...

In this important study, the authors used a zebrafish model and scRNAseq analysis to show that a subset of keratinocytes within melanoma microenvironment highly up-regulate Twist and undergo ...

Evan Williams' third-down stop of Kyler Murray set up Christian Watson's touchdown that put the Packers in front 24-0 against ...